Neogenomics Inc
NEO· Nasdaq
Filed Nov 6, 2015 · 10-Q · 37 days after period end · 0001564590-15-009957
| Metric | Q3 2015 | Q3 2014 | Q3 2013 | Q3 2012 |
|---|---|---|---|---|
| Net Income | -$125.00K | -$291.00K | $900.00K | -$975.00K |
| EPS Diluted | $0.00 | -$0.01 | $0.02 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Neogenomics Inc · CIK 1077183 · Engraved from SEC EDGAR
ended Sep 30, 2015 · filed Nov 6, 2015 · 37 d after period end